Europe’s reliance on plasma imports poses supply risks, Deutsche Bank says
XLV•Europe’s reliance on imported plasma poses supply risks from regulatory changes in supplier countries and international disruptions. Increasing donations alone may not resolve shortages; technology and production capacity must also expand.
1. Supply risks
Europe’s reliance on plasma imports poses strategic supply risks from regulatory changes in supplier countries or international supply-chain disruptions. Increasing European plasma donations alone will not resolve shortages; technology and production capacity must also expand.
2. Grifols’ position
Spain’s Grifols supports European self-sufficiency in plasma-derived medicines, with long-term financing helping expand research, production and international operations.
